Research output per year
Research output per year
Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/15 → 31/10/19 |
Funding
- NHMRC - National Health and Medical Research Council (Australia): A$369,436.00
-
Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions
Kostoulias, X., Fu, Y., Morris, F. C., Yu, C., Qu, Y., Chang, C. C., Blakeway, L., Landersdorfer, C. B., Abbott, I. J., Wang, L., Wisniewski, J., Yu, Y., Li, J. & Peleg, A. Y., Feb 2025, In: Journal of Antimicrobial Chemotherapy. 80, 2, p. 372-380 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia
Kostoulias, X., Chang, C. C., Wisniewski, J., Abbott, I. J., Zisis, H., Dennison, A., Spelman, D. W. & Peleg, A. Y., Aug 2023, In: Pathology. 55, 5, p. 663-668 6 p.Research output: Contribution to journal › Article › Research › peer-review
6 Link opens in a new tab Citations (Scopus) -
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size
Rasmussen, T. A., Ahuja, S. K., Kuwanda, L., Vjecha, M. J., Hudson, F., Lal, L., Rhodes, A., Chang, J., Palmer, S., Auberson-Munderi, P., Mugerwa, H., Wood, R., Badal-Faesen, S., Pillay, S., Mngqibisa, R., LaRosa, A., Hildago, J., Petoumenos, K., Chiu, C. & Lutaakome, J. & 8 others, , 14 Nov 2022, In: Clinical Infectious Diseases. 75, 10, p. 1781-1791 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access10 Link opens in a new tab Citations (Scopus)